Ten scientists associated with the Charlotte Lozier Institute decided to take legal steps against the known naut publishing houseSage Publications. Reason? Withdrawal of their work on the effects of Mifepristone early-poron pill. Researchers accuse the publishing home of discrimination and violation of rules inthe feasibility of technological research, which, in their opinion, poses a serious threat to free technological debate.
Mifepristone investigation Dispute
One of the withdrawn studies, published in November 2021, indicates that the number of emergency emergency visits in women after pharmacological abortion increased 5 times between 2002 and 2015. The second study, published in May 2022, afraid the hazard of re-use of medical assistance by women who had had an abortion utilizing pills. Both works were recalled by national justice Matthew Kacsmaryk, who suspended the decision of the Food and Drug Agency (FDA) to let Mifepristone to market. The justice besides ruled that the medicine should not be distributed by post or prescribed by teleporadia.
Controversy around the decision of the publishing house
The decision to retreat the investigation was made shortly before the U.S. ultimate Court examined the issue of Mifepristone availability. As the regular Wire website notes, this raises additional doubts about the intention of the release. Scientists claim that Sage Publications' decision was unjustified and discriminatory, which violates the principles of free research. Representatives of their lawyers emphasize that researchers endure serious occupational and individual harm, including limiting the anticipation of further investigation and publication.
Double standards?
The regular Wire draws attention to possible double standards in the publishing business. It points out that Sage Journals published many studies of authors related to pro-abortion groups in which no conflict of interest was declared. An example is an article that advocates access to Mifepristone, whose main author is simply a supporter of abortion, and the another authors are associated with an academic center promoting abortion. Similarly, no conflict of interest was revealed in another article, written by a investigator at the Guttmacher Institute.
No comment from the release
So far, Sage Publications has not commented on the withdrawal of investigation or the allegations made by scientists. However, this dispute raises crucial questions about freedom of research, transparency in publishing results and ethics in science.
Conclusion
The dispute between scientists and Sage Publications is not only a legal issue, but besides an crucial voice in the debate on freedom of investigation and ethics in science. The decision to retreat investigation on Mifepristone raises doubts as to the transparency and impartiality of the publishing house, especially in the context of the upcoming consideration of the availability of the pill by the U.S. ultimate Court.
Tags: Mifepristone, Pharmacological Abortion, Research, Sage Publications, Charlotte Lozier Institute, Freedom of Research, Discrimination in Science, U.S. ultimate Court, FDA, regular Wire, Ethics in Science, Conflict of Interest, Medical Research
More here:
Researchers vs. Publishing: A dispute over the withdrawal of publications on harmful abortion pills
